Zinc-Enhanced Bone Tissue Engineering

Zinc has emerged as a pivotal bioactive element in bone tissue engineering, leveraging its intrinsic roles in skeletal growth, mineralisation and cellular regulation. As a trace element, zinc modulates osteoblast proliferation and differentiation while inhibiting osteoclast activity, thereby shifting the balance towards bone formation. Incorporation of zinc into implant surfaces, bioresorbable metal alloys and composite scaffolds enhances mechanical support and stimulates local biological responses. Zinc ions influence key signalling pathways—such as TGF-β/Smad and Runx2-driven gene networks—promoting extracellular matrix deposition and apatite formation. Recent advances focus on additive manufacturing of zinc-alloy scaffolds, controlled ion release systems and surface functionalisation strategies to achieve optimal osseointegration and accelerated defect repair. The global significance of these approaches spans orthopaedic fixation, fracture healing and regenerative therapies for osteoporotic patients.

Research from Nature Portfolio

Surface functionalisation with zinc-containing calcium silicate coatings on titanium alloys has demonstrated marked improvements in implant performance under osteopenic conditions. Enhanced proliferation and osteogenic differentiation of bone marrow-derived progenitor cells were observed in vitro, driven by activation of the TGF-β/Smad signalling cascade. In vivo studies further revealed increased new bone formation around coated implants, indicating potential benefits for patients with compromised bone quality. Earlier foundational work on zinc-modified titanium surfaces applied to dental pulp stem cells showed up-regulation of osteoblast markers—including collagen type I, alkaline phosphatase and Runx2—and enhanced matrix mineralisation. These surface engineering strategies illustrate how controlled zinc release at the implant interface can orchestrate cellular responses critical to bone regeneration.

Research from all publishers

A multi-scale investigation of long bone fracture healing in a rodent model mapped the spatio-temporal distribution of zinc alongside matrix remodelling enzymes. Results indicated that zinc accumulation coincided with early hydroxyapatite deposition and subsequent remodelling phases, highlighting its dual role in mineralisation and resorption. Another study developed β-tricalcium phosphate/poly(L-lactic acid) scaffolds with sustained zinc release, demonstrating synergistic osteoinductive and immunomodulatory effects. Released zinc ions promoted transition of macrophages from a pro-inflammatory M1 phenotype to a pro-healing M2 phenotype via the PI3K/Akt/mTOR pathway, while concurrently enhancing periosteal progenitor cell differentiation and in vivo bone repair. A recent comprehensive review synthesised molecular pathways by which zinc regulates osteoblast and osteoclast function, and surveyed emerging biomaterials enriched in zinc for bone filling and regeneration. These diverse approaches underscore the versatility of zinc-based strategies across material classes and biological contexts.

Zinc-Enhanced Bone Tissue Engineering publication trend

The graph below shows the total number of articles in zinc-enhanced bone tissue engineering across all publications each year (not limited to Nature Index journals).

Technical terms

Osteogenic differentiation: The process by which progenitor cells mature into bone-forming osteoblasts, marked by expression of specific transcription factors and matrix proteins.

Osseointegration: The direct structural and functional connection between living bone and the surface of an implant, crucial for implant stability.

Scaffold: A three-dimensional biomaterial structure designed to support cell attachment, proliferation and tissue formation during regeneration.

Immunomodulation: The alteration of immune cell behaviour to create a pro-healing environment, often by directing macrophage phenotype towards tissue repair.

Hydroxyapatite: A naturally occurring mineral form of calcium phosphate that constitutes the primary inorganic component of bone, used as a bioactive coating or additive in scaffolds.

References

1. Evolution from Bioinert to Bioresorbable: In Vivo Comparative Study of Additively Manufactured Metal Bone Scaffolds. Advanced Science (2023).
2. Multi-scale characterization of the spatio-temporal interplay between elemental composition, mineral deposition and remodelling in bone fracture healing. Acta Biomaterialia (2023).
3. Zinc as a Therapeutic Agent in Bone Regeneration. Materials (2020).
4. Runx2/Osterix and Zinc Uptake Synergize to Orchestrate Osteogenic Differentiation and Citrate Containing Bone Apatite Formation. Advanced Science (2018).
5. Zinc-modified Calcium Silicate Coatings Promote Osteogenic Differentiation through TGF-β/Smad Pathway and Osseointegration in Osteopenic Rabbits. Scientific Reports (2017).
6. Zinc-modified titanium surface enhances osteoblast differentiation of dental pulp stem cells in vitro. Scientific Reports (2016).
7. Sustained zinc release in cooperation with CaP scaffold promoted bone regeneration via directing stem cell fate and triggering a pro-healing immune stimuli. Journal of Nanobiotechnology (2021).
8. Zinc inhibits osteoclast differentiation by suppression of Ca2+-Calcineurin-NFATc1 signaling pathway. Cell Communication and Signaling (2013).